Eupraxia Pharmaceuticals Inc.
HealthcareNASDAQ:EPRX · NASDAQ Global Market
+$0.01 today
Vol 0.14M · Avg 0.22M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+56.48%
Period High
$9.07
Period Low
$3.86
Latest
$6.04
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
SELLAS Life Sciences Group, Inc.
NASDAQ:SLS
$1.12B
Genfit S.A.
GNFT
$445.68M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$284.66M
Cartesian Therapeutics, Inc.
NASDAQ:RNAC
$279.42M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$245.51M
Inventiva S.A.
NASDAQ:IVA
$200.13M
MediWound Ltd.
NASDAQ:MDWD
$154.46M
Protara Therapeutics, Inc.
NASDAQ:TARA
$150.50M
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
$94.98M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$85.08M
What is the latest EPRX filing?
The latest filing shown is 6-K dated May 29, 2026.
How many recent filings does EPRX have?
Intrinsic Alpha currently shows 20 recent filings for EPRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.